Thermo Fisher Scientific will collaborate with Janssen scientists to validate multiple biomarkers, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer.
Read MoreSperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
Targeted cancer treatment using an ALK inhibitor in combination with a PIM1 inhibitor can increase the chances of survival of children with an unfavorable prognosis.
Read MoreT2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More
Caris Life Sciences’ Molecular Intelligence GPS score aids in the characterization of cancer of unknown primary and atypical cases, while also identifying appropriate treatment options.
Read More